GABAPENTIN

Product NDC
50436-0383
11-digit product format
504360383
Labeler code
50436
Product ID
50436-0383_a8bcaed9-cb2e-4e4a-8244-72a4936fff61
Type
HUMAN PRESCRIPTION DRUG
Nonproprietary name
GABAPENTIN
Dosage form
CAPSULE
Route
ORAL
Labeler
Unit Dose Services
Application
ANDA204989
Marketing category
ANDA
Marketing start
2016-09-30
Marketing end
0000-00-00
Substance
GABAPENTIN
Active strength
100 mg/1
Pharmacologic classes
Anti-epileptic Agent [EPC],Decreased Central Nervous System Disorganized Electrical Activity [PE]
NDC exclude flag
No
Listing certified through
2022-12-31
Current FDA listing
Historical FDA.report record

DailyMed Product Concepts#

Product concept, Relation, Version table
Product conceptRelationVersionEffective
cdc2ae60-922e-452d-a42f-787fe4e2ed06Product name120250123
7059096a-4b9f-36c2-db50-bb5c723e6e9eProduct name220250114
fa3f0129-3502-889f-f424-3a37727959e7Product name920181206
77d89e4c-f57f-326d-d7aa-787f8eebbd2bProduct name120140508

FDA-Initiated Inactive NDC Indexing#

NDC, Effective, Action table
NDCEffectiveActionDocumentIndexing SPLRelated label
50436-0383-12023-01-30C16284748780-1ba0f9c33-2d87-a910-e053-dadaa90a0b85These highlights do not include all the information needed to use GABAPENTIN safely and effectively. See full prescribing information for GABAPENTIN. GABAPENTIN capsules, for oral use GABAPENTIN tablets, for oral use Initial U.S. Approval: 1993
50436-0383-42023-01-30C16284748780-1ba0f9c33-2d87-a910-e053-dadaa90a0b85These highlights do not include all the information needed to use GABAPENTIN safely and effectively. See full prescribing information for GABAPENTIN. GABAPENTIN capsules, for oral use GABAPENTIN tablets, for oral use Initial U.S. Approval: 1993
50436-0383-92023-01-30C16284748780-1ba0f9c33-2d87-a910-e053-dadaa90a0b85These highlights do not include all the information needed to use GABAPENTIN safely and effectively. See full prescribing information for GABAPENTIN. GABAPENTIN capsules, for oral use GABAPENTIN tablets, for oral use Initial U.S. Approval: 1993
50436-0383-42021-12-01C16284748780-1ba0f9c33-2d87-a910-e053-dadaa90a0b85These highlights do not include all the information needed to use GABAPENTIN safely and effectively. See full prescribing information for GABAPENTIN. GABAPENTIN capsules, for oral use GABAPENTIN tablets, for oral use Initial U.S. Approval: 1993
50436-0383-92021-12-01C16284748780-1ba0f9c33-2d87-a910-e053-dadaa90a0b85These highlights do not include all the information needed to use GABAPENTIN safely and effectively. See full prescribing information for GABAPENTIN. GABAPENTIN capsules, for oral use GABAPENTIN tablets, for oral use Initial U.S. Approval: 1993
50436-0383-42021-01-29C16284748780-1ba0f9c33-2d87-a910-e053-dadaa90a0b85These highlights do not include all the information needed to use GABAPENTIN safely and effectively. See full prescribing information for GABAPENTIN. GABAPENTIN capsules, for oral use GABAPENTIN tablets, for oral use Initial U.S. Approval: 1993
50436-0383-92021-01-29C16284748780-1ba0f9c33-2d87-a910-e053-dadaa90a0b85These highlights do not include all the information needed to use GABAPENTIN safely and effectively. See full prescribing information for GABAPENTIN. GABAPENTIN capsules, for oral use GABAPENTIN tablets, for oral use Initial U.S. Approval: 1993

DailyMed Package Descriptions#

Package NDC, Product, Description table
Package NDCProductDescriptionFormQuantityStrengthSPL version
50436-0383-1GABAPENTIN30 in 1 BOTTLECAPSULE3010
50436-0383-4GABAPENTIN24 in 1 BOTTLECAPSULE2410
50436-0383-9GABAPENTIN9 in 1 BOTTLECAPSULE910

DailyMed Billing Units#

Package NDC, Billing unit, Product NDC table
Package NDCBilling unitProduct NDCDailyMed indexing SPLSPL versionEffective
50436-0383-1EA - Each50436-0383dd8cd4ea-2c11-46b3-a028-81f49e12083112021-12-08

DailyMed Dashboard NDC Coverage#

NDC, Dashboard title, SPL version table
NDCDashboard titleSPL versionValidationDashboard ZIP
50436-0383GABAPENTIN CAPSULE [UNIT DOSE SERVICES]10Legacy NDC, 3 package rows20211208_55b856aa-2835-4b96-9e52-08c375179b4a.zip

DailyMed RxNorm Mappings#

RxCUI, RxNorm string, TTY table
RxCUIRxNorm stringTTYDailyMedSPL version
310430gabapentin 100 MG Oral CapsulePSN55b856aa-2835-4b96-9e52-08c375179b4a10
310431gabapentin 300 MG Oral CapsulePSN55b856aa-2835-4b96-9e52-08c375179b4a10
310430gabapentin 100 MG Oral CapsuleSCD55b856aa-2835-4b96-9e52-08c375179b4a10
310431gabapentin 300 MG Oral CapsuleSCD55b856aa-2835-4b96-9e52-08c375179b4a10

Packages#

Package NDC, 11-digit format, Description table
Package NDC11-digit formatDescriptionUnitsMarketing startMarketing endSampleExclude flagStatus
50436-0383-15043603830130 CAPSULE in 1 BOTTLE (50436-0383-1) 30 capsule2021-11-010000-00-00NoNoCurrent
50436-0383-45043603830424 CAPSULE in 1 BOTTLE (50436-0383-4) 24 capsule2018-11-090000-00-00NoNoCurrent
50436-0383-9504360383099 CAPSULE in 1 BOTTLE (50436-0383-9) 9 capsule2018-11-090000-00-00NoNoCurrent